A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age

NCT04682353 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: TV-46046
DRUG: Depo-subQ Provera

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]